Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$100.73 - $112.44 $81,692 - $91,188
-811 Reduced 8.81%
8,393 $872,000
Q4 2023

Jan 02, 2024

BUY
$90.19 - $110.4 $12,356 - $15,124
137 Added 1.51%
9,204 $1.02 Million
Q3 2023

Oct 10, 2023

BUY
$95.53 - $114.62 $866,170 - $1.04 Million
9,067 New
9,067 $878,000
Q4 2022

Jan 06, 2023

SELL
$95.06 - $111.52 $101,048 - $118,545
-1,063 Reduced 8.98%
10,777 $1.18 Million
Q4 2021

Jan 11, 2022

SELL
$115.53 - $141.46 $24,607 - $30,130
-213 Reduced 1.77%
11,840 $1.67 Million
Q3 2021

Oct 18, 2021

SELL
$116.66 - $129.06 $19,482 - $21,553
-167 Reduced 1.37%
12,053 $1.4 Million
Q2 2021

Jul 07, 2021

SELL
$105.79 - $124.53 $123,245 - $145,077
-1,165 Reduced 8.7%
12,220 $1.42 Million
Q1 2021

May 03, 2021

SELL
$108.84 - $128.23 $132,022 - $155,542
-1,213 Reduced 8.31%
13,385 $1.6 Million
Q4 2020

Feb 18, 2021

BUY
$105.0 - $114.42 $102,480 - $111,673
976 Added 7.16%
14,598 $1.6 Million
Q3 2020

Nov 03, 2020

BUY
$91.64 - $111.29 $1.02 Million - $1.24 Million
11,161 Added 453.51%
13,622 $1.48 Million
Q2 2020

Jul 20, 2020

BUY
$76.57 - $98.0 $188,438 - $241,178
2,461 New
2,461 $225,000
Q4 2019

Feb 12, 2020

SELL
$78.51 - $87.4 $1.46 Million - $1.63 Million
-18,651 Closed
0 $0
Q3 2019

Nov 04, 2019

SELL
$81.84 - $88.74 $22,833 - $24,758
-279 Reduced 1.47%
18,651 $1.56 Million
Q2 2019

Aug 07, 2019

SELL
$72.88 - $85.0 $273,518 - $319,005
-3,753 Reduced 16.55%
18,930 $1.59 Million
Q1 2019

May 13, 2019

BUY
$66.22 - $80.06 $227,531 - $275,086
3,436 Added 17.85%
22,683 $1.81 Million
Q4 2018

May 22, 2019

BUY
$65.56 - $74.27 $1.26 Million - $1.43 Million
19,247 New
19,247 $1.39 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Symmetry Partners, LLC Portfolio

Follow Symmetry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Symmetry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Symmetry Partners, LLC with notifications on news.